1 citations · 1 across the 2 of their papers we have counts for
3 papers
Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies
Sakshi Piplani, Puneet Singh, David A. Winkler +1
For fast development of COVID-19, it is only feasible to use drugs (off label use) or approved natural products that are already registered or been assessed for safety in previous…
Computational screening of repurposed drugs and natural products against SARS-Cov-2 main protease (Mpro) as potential COVID-19 therapies
Sakshi Piplani, Puneet Singh, Nikolai Petrovsky +1
There remains an urgent need to identify existing drugs that might be suitable for treating patients suffering from COVID-19 infection. Drugs rarely act at a single molecular targe…
In silico comparison of spike protein-ACE2 binding affinities across species; significance for the possible origin of the SARS-CoV-2 virus
Sakshi Piplani, Puneet Kumar Singh, David A. Winkler +1
The devastating impact of the COVID-19 pandemic caused by SARS coronavirus 2 (SARS CoV 2) has raised important questions about viral origin, mechanisms of zoonotic transfer to huma…